Anesthetic Effect - Pipeline Review, H2 2018

Publisher Name :
Date: 11-Sep-2018
No. of pages: 83
Inquire Before Buying

Anesthetic Effect - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anesthetic Effect - Pipeline Review, H2 2018, provides an overview of the Anesthetic Effect (Central Nervous System) pipeline landscape.

Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history of adverse reactions to anesthesia and drug allergies.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Anesthetic Effect - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Anesthetic Effect (Central Nervous System)

List of TablesNumber of Products under Development for Anesthetic Effect, H2 2018 9Number of Products under Development by Companies, H2 2018 The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Anesthetic Effect (Central Nervous System) pipeline guide

List of TablesNumber of Products under Development for Anesthetic Effect, H2 2018 9Number of Products under Development by Companies, H2 2018 The guide covers therapeutics under Development by Companies /Universities /Institutes,

List of TablesNumber of Products under Development for Anesthetic Effect, H2 2018 9Number of Products under Development by Companies, H2 2018

Anesthetic Effect (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is

List of TablesNumber of Products under Development for Anesthetic Effect, H2 2018 9Number of Products under Development by Companies, H2 2018 Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Anesthetic Effect (Central Nervous System).

- The pipeline guide reviews pipeline therapeutics for Anesthetic Effect (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Anesthetic Effect (Central Nervous System) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Anesthetic Effect (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Anesthetic Effect (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Anesthetic Effect (Central Nervous System).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Anesthetic Effect (Central Nervous System) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Anesthetic Effect - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Anesthetic Effect - Overview
Anesthetic Effect - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Anesthetic Effect - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Anesthetic Effect - Companies Involved in Therapeutics Development
Biolab Farmaceutica Ltda
Crescita Therapeutics Inc
Drawbridge Pharmaceuticals Pty Ltd
Expanesthetics Inc
Lannett Company Inc
Lee's Pharmaceutical Holdings Ltd
MedinCell SA
Paion AG
Phosphagenics Ltd
Physica Pharma
Recro Pharma Inc
Sichuan Kelun Pharmaceutical Co Ltd
Sphaera Pharma Pte Ltd
The Medicines Company
YiChang Humanwell Pharmaceutical Co Ltd
Anesthetic Effect - Drug Profiles
(lidocaine + prilocaine) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
alphaxalone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aom-0765 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Carboetomidate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cocaine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cysteine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXPS-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXPS-05 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXPS-09 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Flexicaine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fospropofol disodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HSK-3486 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KL-100137 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lidocaine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lidocaine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDC-CMV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Methoxycarbonyl Carboetomidate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Methoxycarbonyl Etomidate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PHY-301 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
remimazolam - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RP-2000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Anesthetic Effect - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit NMDA Receptor for Anesthesia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SPR-819 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Anesthetic Effect - Dormant Projects
Anesthetic Effect - Discontinued Products
Anesthetic Effect - Product Development Milestones
Featured News & Press Releases
Jul 24, 2018: PAION starts EU Phase III trial with remimazolam in general anesthesia
Apr 30, 2018: Recro Pharma Presents Data for Neuromuscular Blocking and Reversal Agents at the AUA 2018 Annual Meeting
Mar 20, 2018: Phosphagenics/Terumo R&D alliance to focus on TPM Injectables: TPM/Oxymorphone Patch Development to move outside Agreement
Dec 01, 2017: Lannett Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine Hydrochloride Topical Solution, A Proprietary Anesthetic Product
Nov 23, 2017: PAION Announces Clinical Development Progress with Remimazolam by its Partner Hana Pharma in South Korea
Nov 09, 2017: Phosphagenics Provides Update on TPM/Propofol Development Program
Sep 28, 2017: European Patent Office Grants Formulation Patent For Remimazolam In The EU
Sep 25, 2017: Lannett's Board Of Directors Initiates CEO Search
Mar 09, 2017: China FDA has Approved Zingo for Pediatric Use Needle-free Local Analgesia as Priority Review for Clinical Trial
Nov 14, 2016: Powder Pharmaceuticals Submits New Drug Application to China FDA and Hong Kong Department of Health for Needle-free Local Analgesia
Oct 27, 2016: Lannett Announces Successful Phase III Clinical Trial Results For Proprietary C-Topical Product
Oct 19, 2016: Positive Remimazolam Phase III Colonoscopy Results Presented at the 2016 American College of Gastroenterology Annual Scientific Meeting
Sep 22, 2016: PAION: Remimazolam Phase III Colonoscopy Data to Be Presented at the American College of Gastroenterology 2016 Meeting
Sep 06, 2016: PAION announces clinical development progress with remimazolam by its Partner Yichang Humanwell in China
Jun 19, 2016: Paion Reports Positive Remimazolam Headline Data In Pivotal U.S. Phase III Study In Procedural Sedation For Colonoscopy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Anesthetic Effect, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Anesthetic Effect - Pipeline by Biolab Farmaceutica Ltda, H2 2018
Anesthetic Effect - Pipeline by Crescita Therapeutics Inc, H2 2018
Anesthetic Effect - Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H2 2018
Anesthetic Effect - Pipeline by Expanesthetics Inc, H2 2018
Anesthetic Effect - Pipeline by Lannett Company Inc, H2 2018
Anesthetic Effect - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2018
Anesthetic Effect - Pipeline by MedinCell SA, H2 2018
Anesthetic Effect - Pipeline by Paion AG, H2 2018
Anesthetic Effect - Pipeline by Phosphagenics Ltd, H2 2018
Anesthetic Effect - Pipeline by Physica Pharma, H2 2018
Anesthetic Effect - Pipeline by Recro Pharma Inc, H2 2018
Anesthetic Effect - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H2 2018
Anesthetic Effect - Pipeline by Sphaera Pharma Pte Ltd, H2 2018
Anesthetic Effect - Pipeline by The Medicines Company, H2 2018
Anesthetic Effect - Pipeline by YiChang Humanwell Pharmaceutical Co Ltd, H2 2018
Anesthetic Effect - Dormant Projects, H2 2018
Anesthetic Effect - Dormant Projects, H2 2018 (Contd..1), H2 2018
Anesthetic Effect - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Anesthetic Effect, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • Global CNS Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
  • Depression - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 504
    Depression - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H2 2018, provides an overview of the Depression (Central Nervous System) pipeline landscape. Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anx......
  • Friedreich Ataxia - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 91
    Friedreich Ataxia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Friedreich Ataxia - Pipeline Review, H2 2018, provides an overview of the Friedreich Ataxia (Central Nervous System) pipeline landscape. Friedreich's ataxia (FA) is a neuromuscular disease that mainly affects the nervous system and the heart. FA is a hereditary disease, caused by a defective gene that can be passed down th......
  • Dyskinesia - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 182
    Dyskinesia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dyskinesia - Pipeline Review, H2 2018, provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape. Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movement. Symptoms include facial grimacing, finger movement, jaw swinging, repetitive chew......
  • Mild Cognitive Impairment - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 106
    Mild Cognitive Impairment - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment - Pipeline Review, H2 2018, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an intermediate stage......
  • Opium (Opioid) Addiction - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 121
    Opium (Opioid) Addiction - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Pipeline Review, H2 2018, provides an overview of the Opium (Opioid) Addiction (Central Nervous System) pipeline landscape. Opioid Addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to ......
  • Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 113
    Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2018, provides an overview of the Neuromyelitis Optica (Devic's Syndrome) (Central Nervous System) pipeline landscape. Neuromyelitis optica (NMO), also known as Devic's disease, is an uncommon neurological condition caused by disease or dam......
  • Global Spinal Cord Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Spinal Cord Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding a......
  • Global Neuropathy Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Neuropathy Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding an......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs